Lipid-based nanoparticles as drug delivery carriers for cancer therapy

• DOI: 10.3389/fonc.2024.1296091
• Publication Date: 2024-04-10T11:46:13Z
• Authors: Ibtesam Waheed; Anwar Ali; Huma Tabassum; Narjis Khatoon; Wing-Fu Lai; Xin Zhou
• Keywords: Biocompatibility; Cancer Therapy; Solid lipid nanoparticle

Cancer is a severe disease that results in death all countries of the world. A nano-based drug delivery approach best alternative, directly targeting cancer tumor cells with improved cellular uptake. Different types nanoparticle-based carriers are advanced for treatment cancer, and to increase therapeutic effectiveness safety therapy, many substances have been looked into as carriers. Lipid-based nanoparticles (LBNPs) significantly attracted interest recently. These natural biomolecules alternate other polymers frequently recycled medicine due their amphipathic properties. Lipid typically provide variety benefits, including biocompatibility biodegradability. This review covers different classes LBNPs, characterization synthesis technologies. discusses most significant advancements lipid nanoparticle technology use administration. Moreover, also emphasized applications used types.